Thursday, February 26, 2015 5:02:08 PM
The section of GOOGLE, MICROSOFT, and other interested parties that pursue BUYOUTS, yes, would probably like to make a quick deal, and maybe there was one at the first meeting, but I truly doubt it! But because most P-Stocks are known to fail, and money at hand is hard to resist, maybe a minimal offer was made, who knows, but wisdom and common sense tells us, especially when it comes to lower echelon employees, is to obtain and study the details of the product, which was undoubtedly the thrust of the first conversations! Not even close to negotiations folks, just a "Knock-on-the-Door" visit for the most part! Then, GOOGLE or MICROSOFT higher officials study those details, and then wait for results of upcoming events of M.S.I., as elucidated by them in those first meeting(s)! No BUYOUT Company wants a deal to take too long, that is for sure, but a year or 2, for a product in a new sector, where nothing much has yet been proven by M.S.I., is probably about right!
BUT, having had discussions with such Companies is proof enough to me that we might have something here, though what other Companies feel cannot be completely ascertained! I am almost certain, after the initial discussions, that the GOOGLE or MICROSOFT officials said in uncertain terms; "It sounds pretty good, lets talk after so-and-so date when results begin to come in!"
Then again, it makes sense that Making a higher offer of 1 Billion or so, to EMOTIV, as has been reported, because they were the first out-of-the-box, and had more to offer to GOOGLE or whomever! Yes, the M.S.I. device has set a new standard, I believe, but where that will take us is anybody's guess!
Because PHD's SCHALK and CHIU have had long term interests in the BCI field, they are sure to have studied EMOTIV thoroughly, and presented new wrinkles in our "SYNAPSE"! At this point, it is only our hope that the product will perform at least as well as the few others out there, and then rely on the COMPACTNESS and LOWER PRICE to become a serious, even dominant competitor!!
The COUNTDOWN to PRODUCTION continues...
G.L.T.A...TWA
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM